Alcantara_2005_Clin.Chem.Lab.Med_43_285

Reference

Title : Butyrylcholinesterase activity and metabolic syndrome in obese patients - Alcantara_2005_Clin.Chem.Lab.Med_43_285
Author(s) : Alcantara VM , Oliveira LC , Rea RR , Suplicy HL , Chautard-Freire-Maia EA
Ref : Clinical Chemistry & Laboratory Medicine , 43 :285 , 2005
Abstract :

Total butyrylcholinesterase activity (EC 3.1.1.8) was previously suggested as a marker for metabolic syndrome. The present study examined total butyrylcholinesterase activity and the relative and absolute activities of two butyrylcholinesterase electrophoretic bands (C(4/5) and C(OF) in 99 obese individuals (body mass index > or = 30 kg/m2) presenting the CHE2 C5- phenotype of the CHE2 gene. Anthropometric, hormonal and biochemical variables already associated with metabolic syndrome were also examined. The data from these obese individuals of the CHE2 C5- phenotype show that total butyrylcholinesterase activity and the absolute activities of the C(4/5) and C(OF) electrophoretic bands are associated with metabolic syndrome and with variables related to it. These butyrylcholinesterase activities do not behave as independent risk factors for metabolic syndrome, but can be considered as secondary markers for this syndrome in obese individuals with the CHE2 C5- phenotype.

PubMedSearch : Alcantara_2005_Clin.Chem.Lab.Med_43_285
PubMedID: 15843232

Related information

Citations formats

Alcantara VM, Oliveira LC, Rea RR, Suplicy HL, Chautard-Freire-Maia EA (2005)
Butyrylcholinesterase activity and metabolic syndrome in obese patients
Clinical Chemistry & Laboratory Medicine 43 :285

Alcantara VM, Oliveira LC, Rea RR, Suplicy HL, Chautard-Freire-Maia EA (2005)
Clinical Chemistry & Laboratory Medicine 43 :285